Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zhang M et al. | Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. | 2006 | Int. Immunopharmacol. | pmid:16782535 |
Kumar S et al. | Phaseolin: a 47.5kDa protein of red kidney bean (Phaseolus vulgaris L.) plays a pivotal role in hypersensitivity induction. | 2014 | Int. Immunopharmacol. | pmid:24468678 |
Napimoga MH et al. | Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. | 2013 | Int. Immunopharmacol. | pmid:23597428 |
Villegas I et al. | A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. | 2003 | Int. Immunopharmacol. | pmid:14636824 |
El-Shazly AE et al. | Tyrosine kinase inhibition is an important factor for gene expression of CRTH2 in human eosinophils and lymphocytes: A novel mechanism for explaining eosinophils recruitment by the neuro-immune axis in allergic rhinitis. | 2017 | Int. Immunopharmacol. | pmid:28222358 |
Kanunfre CC et al. | Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. | 2004 | Int. Immunopharmacol. | pmid:15251113 |
Wu P et al. | Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. | 2007 | Int. Immunopharmacol. | pmid:17761349 |
Azuma Y et al. | 15-Deoxy-delta(12,14)-prostaglandin J2 is a negative regulator of macrophage functions. | 2001 | Int. Immunopharmacol. | pmid:11710539 |
Kristensen DM et al. | Paracetamol (acetaminophen), aspirin (acetylsalicylic acid) and indomethacin are anti-androgenic in the rat foetal testis. | 2012 | Int. J. Androl. | pmid:22612476 |
Chou YH et al. | The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. | 2005 | Int. J. Biochem. Cell Biol. | pmid:15618017 |
Yu JH et al. | SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. | 2008 | Int. J. Biochem. Cell Biol. | pmid:18035585 |
Baudouin-Legros M et al. | Long-term CFTR inhibition modulates 15d-prostaglandin J2 in human pulmonary cells. | 2012 | Int. J. Biochem. Cell Biol. | pmid:22481026 |
Castellani ML et al. | Rat basophilic leukemia cells (RBL-2H3) generate prostaglandin D2 (PGD2) after regulated upon activation, normal T-cell expressed and secreted (RANTES) activation. | 2006 Oct-Dec | Int. J. Biol. Markers | pmid:17177158 |
Fukuoka T et al. | Prostaglandin D synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ. | 2015 | Int. J. Cancer | pmid:25516376 |
Higashida H et al. | Cytotoxic action of prostaglandin D2 on mouse neuroblastoma cells. | 1983 | Int. J. Cancer | pmid:6574994 |
Winnett G et al. | Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. | 2003 | Int. J. Cancer | pmid:12494466 |
Badawi AF and Badr MZ | Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. | 2003 | Int. J. Cancer | pmid:12455057 |
D'Onofrio C et al. | Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells. | 1992 | Int. J. Cancer | pmid:1592539 |
Radziszewski W et al. | Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins. | 1995 | Int. J. Cardiol. | pmid:8586470 |
Koyani CN et al. | 15-deoxy-Δ¹²,¹â´-PGJâ‚‚ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis. | 2014 | Int. J. Cardiol. | pmid:24698234 |
Shah S et al. | Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. | 2010 | Int. J. Clin. Pract. | pmid:20518948 |
Ikai K and Imamura S | Prostaglandin D2 in the skin. | 1988 | Int. J. Dermatol. | pmid:3286543 |
Franzese O et al. | Functional antagonism between IL-2 and PGA1 or PGJ2 in the control of proliferation of human cord blood-derived mononuclear cells. | 1996 | Int. J. Immunopharmacol. | pmid:9089005 |
Tsujimoto S et al. | Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ. | 2016 | Int. J. Mol. Med. | pmid:27431935 |
Li H and Narahara H | 15-Deoxy-Δ(12,14)-prostaglandin J(2) induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer cell lines. | 2013 | Int. J. Mol. Med. | pmid:23403520 |
Joos H et al. | Single impact trauma in human early-stage osteoarthritic cartilage: implication of prostaglandin D2 but no additive effect of IL-1β on cell survival. | 2011 | Int. J. Mol. Med. | pmid:21567074 |
Kase K et al. | Inhibitory action of roxithromycin on histamine release and prostaglandin D2 production from beta-defensin 2-stimulated mast cells. | 2009 | Int. J. Mol. Med. | pmid:19212651 |
Jung WK et al. | The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells. | 2014 | Int. J. Mol. Med. | pmid:24337644 |
Yoshimura R et al. | The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. | 2003 | Int. J. Mol. Med. | pmid:14612958 |
Okano H et al. | The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells. | 2003 | Int. J. Mol. Med. | pmid:14612959 |
Hogrefe C et al. | Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. | 2012 | Int. J. Mol. Med. | pmid:22922824 |
Moriai M et al. | Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells. | 2009 | Int. J. Oncol. | pmid:19360348 |
Haslmayer P et al. | The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. | 2002 | Int. J. Oncol. | pmid:12239635 |
Hayashi N et al. | Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma. | 2004 | Int. J. Oncol. | pmid:14654945 |
Matsuzaki Y et al. | 15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. | 2005 | Int. J. Oncol. | pmid:16010433 |
Morosetti R et al. | The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. | 2004 | Int. J. Oncol. | pmid:15254749 |
Shim J et al. | The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells. | 2010 | Int. J. Oncol. | pmid:19956851 |
Cekanova M et al. | Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells. | 2008 | Int. J. Oncol. | pmid:18360708 |
Takashima T et al. | PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. | 2001 | Int. J. Oncol. | pmid:11494023 |
Baker DG et al. | Cellular and chemical mediators of type 1 hypersensitivity in calves infected with Ostertagia ostertagi: histamine, prostaglandin D2, prostaglandin E2 and leukotriene C4. | 1993 | Int. J. Parasitol. | pmid:8359983 |
Hovsepian E et al. | Modulation of inflammatory response and parasitism by 15-Deoxy-Δ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. | 2011 | Int. J. Parasitol. | pmid:21215746 |
Gal D et al. | Effect of radiation on prostaglandin production by human bowel in vitro. | 1984 | Int. J. Radiat. Oncol. Biol. Phys. | pmid:6588048 |
Marshall JC | Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? | 2005 | Intensive Care Med | pmid:15782317 |
Hauser B et al. | Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. | 2006 | Intensive Care Med | pmid:16534570 |
Marzocco S et al. | The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. | 2005 | Intensive Care Med | pmid:15868139 |
Choi IK et al. | PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo. | 2008 | Invest New Drugs | pmid:18161004 |
Bhuyan BK et al. | Cytotoxicity of combinations of prostaglandin D2 (PGD2) and antitumor drugs for B16 melanoma cells in culture. | 1986 | Invest New Drugs | pmid:3473056 |
Woodward DF et al. | Studies on the ocular pharmacology of prostaglandin D2. | 1990 | Invest. Ophthalmol. Vis. Sci. | pmid:2298534 |
Miller NR et al. | Sustained neuroprotection from a single intravitreal injection of PGJâ‚‚ in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy. | 2014 | Invest. Ophthalmol. Vis. Sci. | pmid:25298416 |
Sakurai S et al. | Retinal capillary pericyte proliferation and c-Fos mRNA induction by prostaglandin D2 through the cAMP response element. | 2002 | Invest. Ophthalmol. Vis. Sci. | pmid:12147615 |
Shao Z et al. | Choroidal involution is a key component of oxygen-induced retinopathy. | 2011 | Invest. Ophthalmol. Vis. Sci. | pmid:21546530 |
Kuriyan AE et al. | Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype. | 2013 | Invest. Ophthalmol. Vis. Sci. | pmid:24135759 |
Touitou V et al. | Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy. | 2013 | Invest. Ophthalmol. Vis. Sci. | pmid:24106118 |
Aoun P et al. | Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. | 2003 | Invest. Ophthalmol. Vis. Sci. | pmid:12824244 |
Weinreb RN et al. | Prostanoids in rabbit aqueous humor: effect of laser photocoagulation of the iris. | 1985 | Invest. Ophthalmol. Vis. Sci. | pmid:3860488 |
Qin S et al. | Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. | 2006 | Invest. Ophthalmol. Vis. Sci. | pmid:17065531 |
Gaetani P et al. | Prostaglandin D2 monitoring in human CSF after subarachnoid hemorrhage: the possible role of prostaglandin D2 in the genesis of cerebral vasospasm. | 1986 | Ital J Neurol Sci | pmid:3456998 |
Urade Y | Twenty-fifth anniversary of the discovery of somnogenic activity of prostaglandin D2: sleep research directed by Osamu Hayaishi. | 2006 May-Jun | IUBMB Life | pmid:16754308 |
Phillips JE et al. | Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma. | 2016 | J Aerosol Med Pulm Drug Deliv | pmid:27111445 |
Higuchi S et al. | Involvement of Th2 cytokines in the mouse model of flutamide-induced acute liver injury. | 2012 | J Appl Toxicol | pmid:21735453 |
Krohn IK et al. | Mast cell FcϵRI density and function dissociate from dependence on soluble IgE concentration at very low and very high IgE concentrations. | 2013 | J Asthma | pmid:23294195 |
Omini C et al. | Prostaglandin D2 (PGD2) potentiates cholinergic responsiveness in guinea-pig trachea. | 1986 | J Auton Pharmacol | pmid:3464602 |
Brunelli G et al. | PGD2 induces pulmonary hyperresponsiveness to acetylcholine in vivo in the guinea-pig. | 1987 | J Auton Pharmacol | pmid:3480891 |
Armour CL et al. | Prostaglandin F2 alpha augments the response to parasympathetic fibre stimulation in an isolated innervated preparation of rabbit trachea. | 1988 | J Auton Pharmacol | pmid:3198665 |
Mori H et al. | Augmentation of antiproliferative activity of recombinant human tumor necrosis factor by delta 12-prostaglandin J2. | 1990 | J Biol Response Mod | pmid:2341865 |
Kaur R et al. | A phenotypic screening approach in cord blood-derived mast cells to identify anti-inflammatory compounds. | 2013 | J Biomol Screen | pmid:23983232 |
Shin JS et al. | Direct analysis of prostaglandin-E2 and -D2 produced in an inflammatory cell reaction and its application for activity screening and potency evaluation using turbulent flow chromatography liquid chromatography-high resolution mass spectrometry. | 2016 | J Chromatogr A | pmid:27524299 |
Willenberg I et al. | Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E(2), D(2) and thromboxane B(2). | 2015 | J Chromatogr A | pmid:25777050 |
Bain G et al. | Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2. | 2012 | J Clin Pharmacol | pmid:22110163 |
Lauring B et al. | Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects. | 2009 | J Clin Pharmacol | pmid:19833861 |
Siegl AM and Daly JW | Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets. | 1985 | J Cyclic Nucleotide Protein Phosphor Res | pmid:2991349 |
Ashby B | Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes. | 1986 | J Cyclic Nucleotide Protein Phosphor Res | pmid:2432105 |
Parson HK et al. | Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing. | 2013 | J Diabetes | pmid:22727040 |
Lin MS et al. | Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. | 2007 | J Dig Dis | pmid:17532820 |
Shashni B et al. | Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology. | 2013 | J Drug Target | pmid:23130662 |
Yamada K et al. | Nose-to-brain delivery of TS-002, prostaglandin D2 analogue. | 2007 | J Drug Target | pmid:17365274 |
Gay SW and Kosher RA | Prostaglandin synthesis during the course of limb cartilage differentiation in vitro. | 1985 | J Embryol Exp Morphol | pmid:3867724 |
Chan BC et al. | Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells. | 2008 | J Ethnopharmacol | pmid:18725279 |
Hyun J et al. | Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk. | 2015 | J Innate Immun | pmid:25171731 |
Cichocka-Jarosz E et al. | Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children. | 2011 | J Investig Allergol Clin Immunol | pmid:21721371 |
Shahab R et al. | Prostaglandins, leukotrienes and perennial rhinitis. | 2004 | J Laryngol Otol | pmid:15318955 |
Urade Y et al. | Molecular mechanism of sleep regulation by prostaglandin D2. | 1996 | J Lipid Mediat Cell Signal | pmid:8906548 |
Negishi M et al. | Biological actions of delta 12-prostaglandin J2. | 1995 | J Lipid Mediat Cell Signal | pmid:8777585 |
Hutchinson SM et al. | Effects of eicosanoids on parameters in isolated rat hepatocytes and isolated rat hepatocyte couplets: protective effects of eicosanoid receptor antagonists. | 1997 | J Lipid Mediat Cell Signal | pmid:9041475 |
Urade Y et al. | Prostaglandin D, E, and F synthases. | 1995 | J Lipid Mediat Cell Signal | pmid:8777570 |
Zhang Y et al. | Simultaneous and high-throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE-LC-MS/MS as inflammatory biomarkers. | 2011 | J Mass Spectrom | pmid:21706677 |
Pérez-Nievas BG et al. | Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. | 2010 | J Neuroinflammation | pmid:20929574 |
Wendeburg L et al. | Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells. | 2009 | J Neuroinflammation | pmid:19751497 |
Xiang Z et al. | 15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells. | 2007 | J Neuroinflammation | pmid:17634127 |
Pierre SR et al. | Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice. | 2009 | J Neuroinflammation | pmid:19630993 |
Liu JH | Circadian variations of prostaglandins in the rabbit aqueous humor. | 2000 | J Ocul Pharmacol Ther | pmid:10673131 |
Madhu C et al. | Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro. | 1998 | J Ocul Pharmacol Ther | pmid:9811228 |
Hashimoto T et al. | Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs. | 2003 | J Ocul Pharmacol Ther | pmid:14733714 |
Farhat A et al. | Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology. | 2011 | J Ovarian Res | pmid:21352547 |
Churi SB et al. | Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats. | 2008 | J Pain | pmid:18387855 |
Mooney JJ et al. | Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study. | 2013 | J Psychiatr Res | pmid:23490066 |
Kershenovich A et al. | Angiotensin II does not mediate the pressor response to PGD2 (icv). | 2000 | J Renin Angiotensin Aldosterone Syst | pmid:11967813 |
Inagaki S et al. | Human liver dihydrodiol dehydrogenase 1-catalyzed reaction generating 9alpha,11beta-prostaglandin F2 from prostaglandin D2 followed by micellar electrokinetic chromatography. | 2008 | J Sep Sci | pmid:18307166 |
Brugger N et al. | Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species. | 2008 | J Sex Med | pmid:18047485 |
Hayaishi O | Prostaglandin D2 and sleep--a molecular genetic approach. | 1999 | J Sleep Res | pmid:10389108 |